Role of inflammatory monocytes in vaccine-induced reduction of helicobacter felis infection

Infection and Immunity

Volumn 83, Issue 11, 2015, Pages 4217-4228

  Moyat, Mati ^a   Mack, Matthias ^b   Bouzourene, Hanifa ^c   Velin, Dominique ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; CD64 ANTIGEN; CHEMOKINE RECEPTOR CCR2; INDUCIBLE NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL COLONIZATION; DEPLETION; FEMALE; FLOW CYTOMETRY; GASTRIC MUCOSA; HELICOBACTER FELIS; HELICOBACTER INFECTION; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BAGG ALBINO MOUSE; GENETICS; HELICOBACTER INFECTIONS; HUMAN; IMMUNOLOGY; MICROBIOLOGY;

ANIMALS; BACTERIAL VACCINES; FEMALE; HELICOBACTER FELIS; HELICOBACTER INFECTIONS; HUMANS; IMMUNIZATION; MICE; MICE, INBRED BALB C; MONOCYTES; NITRIC OXIDE SYNTHASE TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84947594003     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01026-15     Document Type: Article

References (54)

1. Frenck RW, Jr, Clemens J. 2003. Helicobacter in the developing world. Microbes Infect 5:705-713. http://dx.doi.org/10.1016/S1286-4579(03)00112-6.
2. Cover TL, Blaser MJ. 2009. Helicobacter pylori in health and disease. Gastroenterology 136:1863-1873. http://dx.doi.org/10.1053/j.gastro.2009.01.073.
3. Farinha P, Gascoyne RD. 2005. Helicobacter pylori and MALT lymphoma. Gastroenterology 128:1579-1605. http://dx.doi.org/10.1053/j.gastro.2005.03.083.
4. Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, Terao S, Amagai K, Hayashi S, Asaka M, Japan Gast Study Group. 2008. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an openlabel, randomised controlled trial. Lancet 372:392-397. http://dx.doi.org/10.1016/S0140-6736(08)61159-9.
5. Ernst PB, Peura DA, Crowe SE. 2006. The translation of Helicobacter pylori basic research to patient care. Gastroenterology 130:188-206. http://dx.doi.org/10.1053/j.gastro.2005.06.032.
6. Wolle K, Malfertheiner P. 2007. Treatment of Helicobacter pylori. Best Pract Res Clin Gastroenterol 21:315-324. http://dx.doi.org/10.1016/j.bpg.2006.11.001.
7. Kreiss C, Buclin T, Cosma M, Corthesy-Theulaz I, Michetti P. 1996. Safety of oral immunisation with recombinant urease in patients with Helicobacter pylori infection. Lancet 347:1630-1631. http://dx.doi.org/10.1016/S0140-6736(96)91119-8.
8. Michetti P, Kreiss C, Kotloff KL, Porta N, Blanco JL, Bachmann D, Herranz M, Saldinger PF, Corthesy-Theulaz I, Losonsky G, Nichols R, Simon J, Stolte M, Ackerman S, Monath TP, Blum AL. 1999. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology 116: 804-812. http://dx.doi.org/10.1016/S0016-5085(99)70063-6.
9. Banerjee S, Medina-Fatimi A, Nichols R, Tendler D, Michetti M, Simon J, Kelly CP, Monath TP, Michetti P. 2002. Safety and efficacy of low dose Escherichia coli enterotoxin adjuvant for urease based oral immunisation against Helicobacter pylori in healthy volunteers. Gut 51:634-640. http://dx.doi.org/10.1136/gut.51.5.634.
10. Sutton P. 2011. Vaccinating against Helicobacter pylori: dissecting the mechanism. Gastroenterology 141:1149-1151. http://dx.doi.org/10.1053/j.gastro.2011.08.026.
11. Ermak TH, Giannasca PJ, Nichols R, Myers GA, Nedrud J, Weltzin R, Lee CK, Kleanthous H, Monath TP. 1998. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J Exp Med 188:2277-2288. http://dx.doi.org/10.1084/jem.188.12.2277.
12. Michetti M, Kelly CP, Kraehenbuhl JP, Bouzourene H, Michetti P.2000. Gastric mucosal alpha(4)beta(7)-integrin-positive CD4 T lymphocytes and immune protection against Helicobacter infection in mice. Gastroenterology 119:109-118. http://dx.doi.org/10.1053/gast.2000.8548.
13. Aebischer T, Laforsch S, Hurwitz R, Brombacher F, Meyer TF. 2001. Immunity against Helicobacter pylori: significance of interleukin-4 receptor alpha chain status and gender of infected mice. Infect Immun 69:556-558. http://dx.doi.org/10.1128/IAI.69.1.556-558.2001.
14. Sawai N, Kita M, Kodama T, Tanahashi T, Yamaoka Y, Tagawa Y, Iwakura Y, Imanishi J. 1999. Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Infect Immun 67:279-285.
15. Velin D, Favre L, Bernasconi E, Bachmann D, Pythoud C, Saiji E, Bouzourene H, Michetti P. 2009. Interleukin-17 is a critical mediator of vaccine-induced reduction of Helicobacter infection in the mouse model. Gastroenterology 136:2237-2246.e1. http://dx.doi.org/10.1053/j.gastro.2009.02.077.
16. Velin D, Bachmann D, Bouzourene H, Michetti P. 2005. Mast cells are critical mediators of vaccine-induced Helicobacter clearance in the mouse model. Gastroenterology 129:142-155. http://dx.doi.org/10.1053/j.gastro.2005.04.010.
17. Ismail HF, Fick P, Zhang J, Lynch RG, Berg DJ. 2003. Depletion of neutrophils in IL-10(-/-) mice delays clearance of gastric Helicobacter infection and decreases the Th1 immune response to Helicobacter. J Immunol 170:3782-3789. http://dx.doi.org/10.4049/jimmunol.170.7.3782.
18. Velin D, Bachmann D, Bouzourene H, Michetti P. 2008. Reduction of Helicobacter infection in IL-10-/-mice is dependent on CD4+ T cells but not on mast cells. Helicobacter 13:361-369. http://dx.doi.org/10.1111/j.1523-5378.2008.00614.x.
19. DeLyria ES, Redline RW, Blanchard TG. 2009. Vaccination of mice against H pylori induces a strong Th-17 response and immunity that is neutrophil dependent. Gastroenterology 136:247-256. http://dx.doi.org/10.1053/j.gastro.2008.09.017.
20. Auffray C, Fogg D, Garfa M, Elain G, Join-Lambert O, Kayal S, Sarnacki S, Cumano A, Lauvau G, Geissmann F. 2007. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 317:666-670. http://dx.doi.org/10.1126/science.1142883.
21. Geissmann F, Jung S, Littman DR. 2003. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19:71-82. http://dx.doi.org/10.1016/S1074-7613(03)00174-2.
22. Biburger M, Aschermann S, Schwab I, Lux A, Albert H, Danzer H, Woigk M, Dudziak D, Nimmerjahn F. 2011. Monocyte subsets responsible for immunoglobulin G-dependent effector functions in vivo. Immunity 35:932-944. http://dx.doi.org/10.1016/j.immuni.2011.11.009.
23. Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo JL, Libby P, Weissleder R, Pittet MJ. 2007. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 204:3037-3047. http://dx.doi.org/10.1084/jem.20070885.
24. Serbina NV, Salazar-Mather TP, Biron CA, Kuziel WA, Pamer EG.2003. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 19:59-70. http://dx.doi.org/10.1016/S1074-7613(03)00171-7.
25. Robben PM, LaRegina M, Kuziel WA, Sibley LD. 2005. Recruitment of Gr-1+ monocytes is essential for control of acute toxoplasmosis. J Exp Med 201:1761-1769. http://dx.doi.org/10.1084/jem.20050054.
26. Hohl TM, Rivera A, Lipuma L, Gallegos A, Shi C, Mack M, Pamer EG.2009. Inflammatory monocytes facilitate adaptive CD4 T cell responses during respiratory fungal infection. Cell Host Microbe 6:470-481. http://dx.doi.org/10.1016/j.chom.2009.10.007.
27. Tsou CL, Peters W, Si Y, Slaymaker S, Aslanian AM, Weisberg SP, Mack M, Charo IF. 2007. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J Clin Invest 117:902-909. http://dx.doi.org/10.1172/JCI29919.
28. Serbina NV, Pamer EG. 2006. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol 7:311-317. http://dx.doi.org/10.1038/ni1309.
29. Shi C, Jia T, Mendez-Ferrer S, Hohl TM, Serbina NV, Lipuma L, Leiner I, Li MO, Frenette PS, Pamer EG. 2011. Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating Toll-like receptor ligands. Immunity 34:590-601. http://dx.doi.org/10.1016/j.immuni.2011.02.016.
30. Ravindran R, Rusch L, Itano A, Jenkins MK, McSorley SJ. 2007. CCR6-dependent recruitment of blood phagocytes is necessary for rapid CD4 T cell responses to local bacterial infection. Proc Natl Acad Sci U S A 104:12075-12080. http://dx.doi.org/10.1073/pnas.0701363104.
31. Rottman JB, Slavin AJ, Silva R, Weiner HL, Gerard CG, Hancock WW.2000. Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent. Eur J Immunol 30:2372-2377. http://dx.doi.org/10.1002/1521-4141(2000)30:8<2372::AID-IMMU2372>3.0.CO;2-D.
32. Auffray C, Fogg DK, Narni-Mancinelli E, Senechal B, Trouillet C, Saederup N, Leemput J, Bigot K, Campisi L, Abitbol M, Molina T, Charo I, Hume DA, Cumano A, Lauvau G, Geissmann F. 2009. CX3CR1+ CD115+ CD135+ common macrophage/DC precursors and the role of CX3CR1 in their response to inflammation. J Exp Med 206: 595-606. http://dx.doi.org/10.1084/jem.20081385.
33. Tacke F, Alvarez D, Kaplan TJ, Jakubzick C, Spanbroek R, Llodra J, Garin A, Liu J, Mack M, van Rooijen N, Lira SA, Habenicht AJ, Randolph GJ. 2007. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 117:185-194. http://dx.doi.org/10.1172/JCI28549.
34. Mitchell C, Couton D, Couty JP, Anson M, Crain AM, Bizet V, Renia L, Pol S, Mallet V, Gilgenkrantz H. 2009. Dual role of CCR2 in the constitution and the resolution of liver fibrosis in mice. Am J Pathol 174: 1766-1775. http://dx.doi.org/10.2353/ajpath.2009.080632.
35. Mack M, Cihak J, Simonis C, Luckow B, Proudfoot AE, Plachy J, Bruhl H, Frink M, Anders HJ, Vielhauer V, Pfirstinger J, Stangassinger M, Schlondorff D. 2001. Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice. J Immunol 166:4697-4704. http://dx.doi.org/10.4049/jimmunol.166.7.4697.
36. Velin D, Narayan S, Bernasconi E, Busso N, Ramelli G, Maillard MH, Bachmann D, Pythoud C, Bouzourene H, Michetti P, So A. 2011. PAR2 promotes vaccine-induced protection against Helicobacter infection in mice. Gastroenterology 141:1273-1282.e1. http://dx.doi.org/10.1053/j.gastro.2011.06.038.
37. Quah BJ, Warren HS, Parish CR. 2007. Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester. Nat Protoc 2:2049-2056. http://dx.doi.org/10.1038/nprot.2007.296.
38. Suzuki C, Aoki-Yoshida A, Kimoto-Nira H, Kobayashi M, Sasaki K, Mizumachi K. 2014. Effects of strains of Lactococcus lactis on the production of nitric oxide and cytokines in murine macrophages. Inflammation 37:1728-1737. http://dx.doi.org/10.1007/s10753-014-9901-6.
39. D'Angelo F, Bernasconi E, Schafer M, Moyat M, Michetti P, Maillard MH, Velin D. 2013. Macrophages promote epithelial repair through hepatocyte growth factor secretion. Clin Exp Immunol 174:60-72. http://dx.doi.org/10.1111/cei.12157.
40. Zigmond E, Varol C, Farache J, Elmaliah E, Satpathy AT, Friedlander G, Mack M, Shpigel N, Boneca IG, Murphy KM, Shakhar G, Halpern Z, Jung S. 2012. Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells. Immunity 37:1076-1090. http://dx.doi.org/10.1016/j.immuni.2012.08.026.
41. Tamoutounour S, Henri S, Lelouard H, de Bovis B, de Haar C, van der Woude CJ, Woltman AM, Reyal Y, Bonnet D, Sichien D, Bain CC, Mowat AM, Reis e Sousa C, Poulin LF, Malissen B, Guilliams M. 2012. CD64 distinguishes macrophages from dendritic cells in the gut and reveals the Th1-inducing role of mesenteric lymph node macrophages during colitis. Eur J Immunol 42:3150-3166. http://dx.doi.org/10.1002/eji.201242847.
42. Dunay IR, Damatta RA, Fux B, Presti R, Greco S, Colonna M, Sibley LD. 2008. Gr1(+) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii. Immunity 29:306-317. http://dx.doi.org/10.1016/j.immuni.2008.05.019.
43. Rydstrom A, Wick MJ. 2007. Monocyte recruitment, activation, and function in the gut-associated lymphoid tissue during oral Salmonella infection. J Immunol 178:5789-5801. http://dx.doi.org/10.4049/jimmunol.178.9.5789.
44. Ngo LY, Kasahara S, Kumasaka DK, Knoblaugh SE, Jhingran A, Hohl TM. 2014. Inflammatory monocytes mediate early and organ-specific innate defense during systemic candidiasis. J Infect Dis 209:109-119. http://dx.doi.org/10.1093/infdis/jit413.
45. Mordue DG, Sibley LD. 2003. A novel population of Gr-1+-activated macrophages induced during acute toxoplasmosis. J Leukoc Biol 74:1015-1025. http://dx.doi.org/10.1189/jlb.0403164.
46. Wilson KT, Crabtree JE. 2007. Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies. Gastroenterology 133:288-308. http://dx.doi.org/10.1053/j.gastro.2007.05.008.
47. Gobert AP, McGee DJ, Akhtar M, Mendz GL, Newton JC, Cheng Y, Mobley HL, Wilson KT. 2001. Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival. Proc Natl Acad Sci U S A 98:13844-13849. http://dx.doi.org/10.1073/pnas.241443798.
48. Zhang Z, Clarke TB, Weiser JN. 2009. Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest 119:1899-1909. http://dx.doi.org/10.1172/JCI36731.
49. Salama NR, Hartung ML, Muller A. 2013. Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori. Nat Rev Microbiol 11:385-399. http://dx.doi.org/10.1038/nrmicro3016.
50. Moyat M, Velin D. 2014. Immune responses to Helicobacter pylori infection. World J Gastroenterol 20:5583-5593. http://dx.doi.org/10.3748/wjg.v20.i19.5583.
51. Rivollier A, He J, Kole A, Valatas V, Kelsall BL. 2012. Inflammation switches the differentiation program of Ly6C hi monocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colon. J Exp Med 209:139-155. http://dx.doi.org/10.1084/jem.20101387.
52. Grainger JR, Wohlfert EA, Fuss IJ, Bouladoux N, Askenase MH, Legrand F, Koo LY, Brenchley JM, Fraser ID, Belkaid Y. 2013. Inflammatory monocytes regulate pathologic responses to commensals during acute gastrointestinal infection. Nat Med 19:713-721. http://dx.doi.org/10.1038/nm.3189.
53. Le Borgne M, Etchart N, Goubier A, Lira SA, Sirard JC, van Rooijen N, Caux C, Ait-Yahia S, Vicari A, Kaiserlian D, Dubois B. 2006. Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo. Immunity 24:191-201. http://dx.doi.org/10.1016/j.immuni.2006.01.005.
54. Zhuang Y, Cheng P, Liu XF, Peng LS, Li BS, Wang TT, Chen N, Li WH, Shi Y, Chen W, Pang KC, Zeng M, Mao XH, Yang SM, Guo H, Guo G, Liu T, Zuo QF, Yang HJ, Yang LY, Mao FY, Lv YP, Zou QM.2014. A pro-inflammatory role for Th22 cells in Helicobacter pyloriassociated gastritis. Gut 64:1368-1378. http://dx.doi.org/10.1136/gutjnl-2014-307020.